News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
2 stories
Tagged Hematology and blood cancers from the headline and teaser, so some stories may be missed or misfiled.
- Trade pressBioPharma DiveNov 18, 2026FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
The FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.
- FDA approvalDrugs@FDANov 13, 2026FDA new use approved: Gazyva (Obinutuzumab), Genentech
Efficacy supplement 44. Priority review.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.